Stock Track | Cellebrite Plunges 6.29% in Pre-Market After Q4 Net Income Misses Estimates
Stock Track
Yesterday
Cellebrite's stock fell 6.29% in pre-market trading on Wednesday, following the release of its fourth-quarter 2025 financial results.
The digital investigative solutions company reported quarterly net income of $21.261 million, which fell short of the analyst consensus estimate of $34 million. This miss on a key profitability metric appears to have driven the negative investor reaction.
Other aspects of the earnings report were more positive, including revenue of $128.821 million that beat estimates and adjusted earnings per share of $0.14 that met expectations. The company also provided full-year 2026 revenue guidance of $565 million to $571 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.